Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Avidity Biosciences, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $100 Billion
- Q4 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 5,621 shares of RNA stock, worth $187,179. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,621
Previous 8,913
36.93%
Holding current value
$187,179
Previous $409,000
60.15%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding RNA
# of Institutions
257Shares Held
100MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11MShares$368 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.43MShares$314 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$287 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$264 Million3.76% of portfolio
-
Avoro Capital Advisors LLC New York, NY7.5MShares$250 Million3.18% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.74B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...